Skip to content
healthcare.dev

ZEJULA

NDC 0173-0912, niraparib, tablet, film coated, from GlaxoSmithKline LLC.

Product NDC
0173-0912
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214876
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0912 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NIRAPARIB TOSYLATE200 mg/1

Pharmacologic classes

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Package NDCNDC-11Package
0173-0912-130017309121330 TABLET, FILM COATED in 1 BOTTLE (0173-0912-13)
0173-0912-610017309126130 TABLET, FILM COATED in 1 BOTTLE (0173-0912-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b7f675e2-159c-490c-b6f4-3f16d9492b7d

Use it

Look up 0173-0912 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0912 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0173-0912. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.